LexaGene Holdings Inc. (CVE:LXG – Get Free Report) shares traded down 19.2% during trading on Wednesday . The company traded as low as C$0.10 and last traded at C$0.11. 2,135,377 shares changed hands during trading, an increase of 1,156% from the average session volume of 170,061 shares. The stock had previously closed at C$0.13.
LexaGene Trading Down 19.2 %
The company has a debt-to-equity ratio of 138.01, a quick ratio of 1.13 and a current ratio of 1.39. The business’s 50 day moving average price is C$0.11 and its two-hundred day moving average price is C$0.11. The company has a market capitalization of C$14.77 million, a price-to-earnings ratio of -1.31 and a beta of 2.26.
About LexaGene
LexaGene Holdings Inc, a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets.
See Also
- Five stocks we like better than LexaGene
- What Do S&P 500 Stocks Tell Investors About the Market?
- Ramaco Resources Pins Hopes on Coal’s Untapped Potential
- What is a buyback in stocks? A comprehensive guide for investors
- NVIDIA’s Soaring Energy Needs Make These 3 Nuclear Stocks a Buy
- Should You Invest in Penny Stocks?
- Why Energy Transfer Belongs on Your Watchlist
Receive News & Ratings for LexaGene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LexaGene and related companies with MarketBeat.com's FREE daily email newsletter.
